599 related articles for article (PubMed ID: 17434581)
41. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies.
Gavini E; Chetoni P; Cossu M; Alvarez MG; Saettone MF; Giunchedi P
Eur J Pharm Biopharm; 2004 Mar; 57(2):207-12. PubMed ID: 15018976
[TBL] [Abstract][Full Text] [Related]
42. Development of a novel AMX-loaded PLGA/zein microsphere for root canal disinfection.
Sousa FF; Luzardo-Alvarez A; Pérez-Estévéz A; Seoane-Prado R; Blanco-Méndez J
Biomed Mater; 2010 Oct; 5(5):055008. PubMed ID: 20844319
[TBL] [Abstract][Full Text] [Related]
43. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods.
Atuah KN; Walter E; Merkle HP; Alpar HO
J Microencapsul; 2003; 20(3):387-99. PubMed ID: 12881118
[TBL] [Abstract][Full Text] [Related]
44. Polyelectrolyte complex of chondroitin sulfate and peptide with lower pI value in poly(lactide-co-glycolide) microsphere for stability and controlled release.
Park W; Na K
Colloids Surf B Biointerfaces; 2009 Sep; 72(2):193-200. PubMed ID: 19414243
[TBL] [Abstract][Full Text] [Related]
45. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
[TBL] [Abstract][Full Text] [Related]
46. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
Khan A; Sommer W; Fuxe K; Akhtar S
J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
[TBL] [Abstract][Full Text] [Related]
47. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
McCarron PA; Marouf WM; Donnelly RF; Scott C
J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
[TBL] [Abstract][Full Text] [Related]
48. Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet.
Manome Y; Kobayashi T; Mori M; Suzuki R; Funamizu N; Akiyama N; Inoue S; Tabata Y; Watanabe M
Anticancer Res; 2006; 26(5A):3317-26. PubMed ID: 17094447
[TBL] [Abstract][Full Text] [Related]
49. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
Lewis KJ; Irwin WJ; Akhtar S
J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
[TBL] [Abstract][Full Text] [Related]
50. Preparation of porous PLGA microspheres with thermoreversible gel to modulate drug release profile of water-soluble drug: bleomycin sulphate.
Chaudhari KR; Shah N; Patel H; Murthy R
J Microencapsul; 2010; 27(4):303-13. PubMed ID: 20128747
[TBL] [Abstract][Full Text] [Related]
51. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
Chavanpatil MD; Patil Y; Panyam J
Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
[TBL] [Abstract][Full Text] [Related]
52. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization.
Elkharraz K; Faisant N; Guse C; Siepmann F; Arica-Yegin B; Oger JM; Gust R; Goepferich A; Benoit JP; Siepmann J
Int J Pharm; 2006 May; 314(2):127-36. PubMed ID: 16490330
[TBL] [Abstract][Full Text] [Related]
53. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
[TBL] [Abstract][Full Text] [Related]
54. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.
Ong BY; Ranganath SH; Lee LY; Lu F; Lee HS; Sahinidis NV; Wang CH
Biomaterials; 2009 Jun; 30(18):3189-96. PubMed ID: 19285718
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
Zolnik BS; Burgess DJ
J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
[TBL] [Abstract][Full Text] [Related]
56. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
57. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
58. Combining oxygen plasma treatment with anchorage of cationized gelatin for enhancing cell affinity of poly(lactide-co-glycolide).
Shen H; Hu X; Yang F; Bei J; Wang S
Biomaterials; 2007 Oct; 28(29):4219-30. PubMed ID: 17618682
[TBL] [Abstract][Full Text] [Related]
59. Development and characterization of interleukin-18-loaded biodegradable microspheres.
Lagarce F; Garcion E; Faisant N; Thomas O; Kanaujia P; Menei P; Benoit JP
Int J Pharm; 2006 May; 314(2):179-88. PubMed ID: 16515850
[TBL] [Abstract][Full Text] [Related]
60. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
Doan TV; Couet W; Olivier JC
Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]